Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

British Journal of Surgery

Volumn 91, Issue 2, 2004, Pages 199-204

  Brown, W A ^a,b   Thomas, J ^a   Gotley, D ^a   Burmeister, B H ^a   Lim, K H ^a   Martin, I ^a   Walpole, E T ^a   Thomson, D B ^a   Harvey, J A ^a   Smithers, B M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Mater Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DRUG RESPONSE; ESOPHAGOGASTROSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROSCOPY; HUMANS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 10744232443     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4411     Document Type: Article

References (26)

1. Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 2001; 72: 1918-1925.
2. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984.
3. Arnott SJ, Duncan W, Gigoux M, Girling DJ, Hansen HS, Launois B et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998; 41: 579-583.
4. Medical Reseach Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
5. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 337: 462-467.
6. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784.
7. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-1110.
8. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41: 391-393.
9. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167.
10. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313.
11. Geh JI, Crellin AM, Glynne-Jones RG. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88: 338-356.
12. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999; 213: 67-72.
13. DeCamp MM Jr, Swanson SJ, Jaklitsch MT. Esophagectomy after induction chemoradiation. Chest 1999; 116(Suppl): 466S-469S.
14. Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181: 440-444.
15. Meneu-Diaz JC. The role of multimodality therapy for resectable esophageal cancer. Am J Surg 2000; 179: 508-513.
16. Smithers BM, Devitt P, Jamison GG, Bessell J, Gotley D, Gill PG et al. A combined modality approach to the management of oesophageal cancer. Eur J Surg Oncol 1997; 23: 219-223.
17. Bessell JR, Devitt PG, Gill PG, Goyal S, Jamison GG. Prolonged survival follows resection of oesophageal SCC downstaged by prior chemoradiotherapy. Aust N Z J Surg 1996; 66: 214-217.
18. Brucher BLDM, Weber W, Bauer M, Fink U, Avril N, Stein HJ et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response by positron emission tomography. Ann Surg 2001; 233: 300-309.
19. Giovannini M, Seitz JF, Thomas P, Hannoun-Levy JM, Perrier H, Resbeut M et al. Endoscopic ultrasonography for assessment of the response to combined radiation and chemotherapy in patients with esophageal cancer. Endoscopy 1997; 29: 4-9.
20. Flamen P, Van Cutsem E, Lerut A, Cambier J-P, Haustermans K, Bormans G et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002; 13: 361-368.
21. Poplin E, Fleming T, Leichman L, Seydel HG, Steiger Z, Taylor S et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study. J Clin Oncol 1987; 5: 622-628.
22. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-163.
23. Triboulet JP, Amrouni H, Guillem P, Vandenhaute B, Lecomte-Houcke M, Adenis A. Devenir des cancers epidermoides de l'oesophage en réponse compléte aprés chimio-radiothérapie pré- opératoire. Ann Chir 1998; 52: 503-507.
24. Jones DR, Detterbeck FC, Egan TM, Parker L, Bernard SA, Tepper JE. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997; 64: 185-192.
25. Imdahl A, Jenkner J, Ihling C, Klaus-Dieter R, Farthmann EH. Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer? Am J Surg 2000; 179: 514-520.
26. Horii N, Nishimura Y, Okuno Y, Kanamori S, Hiraoka M, Shimada Y et al. Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2001; 49: 527-532.